US-based diabetes management device manufacturer TypeZero Technologies was acquired by glucose monitoring provider Dexcom yesterday, marking the first exit for the University of Virginia Licensing and Ventures Group (UVA LVG) Seed Fund.
Financial terms were not disclosed. The Seed Fund is a $10m vehicle launched by the university’s commercialisation arm, UVA LVG, to back university-linked companies.
Founded in 2013, TypeZero Technologies develops diabetes management tools, called InControl, that include a smartphone-operated artificial pancreas system to help the patient keep track…
